Moreover, As shown in Figure 6E and Figure 6F, prognosis analysis suggested a poor overall survival in STAD patients with high NR1D1 expression (p = 0.012) and PER1 expression (p = 0.0064), These data further verified above results. This evidence concerns the gene NR1D1 and gastric adenocarcinoma.